中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:(Xingjun XU)

1.THE METHODS OF MULTIMODALITY IN THE TREATMENT OF 65 CASES OF OSTEOGENIC SARCOMA OF BONE (ANALYSIS REPORT)

Dongyue HU ; Ying XUE ; Xingjun XU

Journal of Xi'an Jiaotong University(Medical Sciences) 1981;0(03):-

2.Clinical value of serum IL-2,IL-6,IL-10,ChE and HA changes in patients with chronic hepatitis B and liver cirrhosis

Song XU ; Xingjun GU ; Guoqi YANG ; Xiaoxia WANG ; Dachun FAN

International Journal of Laboratory Medicine 2014;(15):1986-1988

3.The Research of Low-Field MR Imaging in the Diagnosis of Chondromalacia Patellae

Yongdong WANG ; Jianhong QI ; Min ZHAO ; Jianzhong ZHU ; Rongchun XU ; Xingjun SONG

Journal of Practical Radiology 1996;0(04):-

4.Related factors in predicting relapse of Graves' disease after treatment with antithyroid drugs

Ling LAN ; Weiping TENG ; Bingyin SHI ; Xingjun LIU ; Hao LI ; Juan LIU ; Xiaoyan WU ; Li XU ; Fangxia WANG

Chinese Journal of Endocrinology and Metabolism 2009;25(3):247-249

5.Pyruvate substituting lactate dialysis solution peritoneal resuscitation on the effects of hemorrhagic shock rabbit liver function

Xingjun LUO ; Ran RAN ; Heying ZHONG ; Gang TIAN ; Daolin JIAN ; Jie XU

The Journal of Practical Medicine 2017;33(17):2830-2833

6.Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer

Shile GAO ; Donghui LU ; Meiqin LIU ; Xingjun XU ; Huan MA ; Yu ZHANG

Journal of International Oncology 2022;49(3):140-145

7.Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma

Xiaobo LIU ; Yanliang BAI ; Ying LIU ; Weiya LI ; Yabin CUI ; Jinhui XU ; Xingjun XIAO ; Xiaona NIU ; Kai SUN

Blood Research 2023;58(4):187-193

8.Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.

Kefan ZHOU ; Jin ZHAO ; Hongjuan XU ; Xuejun YAN ; Weidong LIU ; Xingjun JIANG ; Caiping REN

Journal of Central South University(Medical Sciences) 2022;47(6):685-697

9.Evaluation of the short-term efficacy and safety of bevacizumab combined with doxorubicin liposomes in the treatment of patients with platinum-resistant recurrent epithelial ovarian cancer

LIU Meiqin ; LU Donghui ; GAO Shile ; XU Xingjun ; ZHANG Yu

Chinese Journal of Cancer Biotherapy 2021;28(8):818-823

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO